We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Crystal Structures Explain Action of Bioscavenger Enzyme

By Biotechdaily staff writers
Posted on 30 Apr 2003
A recent study presented the first crystal structures of analogs of cocaine and heroin bound to the human enzyme carboxylesterase 1 (hCE1), a broad-spectrum bioscavenger that catalyzes the hydrolysis of heroin and cocaine as well as the detoxification of organophosphate chemical weapons, such as sarin, soman, and tabun. More...


The study, published April 7, 2003, in the online edition of Nature Structural Biology, revealed how humans initiate the breakdown of both narcotics and organophosphates. Investigators at the University of North Carolina (Chapel Hill, USA) employed the cocaine analog homatropine and the heroin analog naloxone to generate crystal structures of the hCE1 glycoprotein in complex with substrate molecules. They found that a selective surface ligand-binding site regulated the trimer-hexamer equilibrium of hCE1 and allowed each hCE1 monomer to bind two narcotic molecules simultaneously.

Senior author Dr. Matthew Redinbo, assistant professor in the department of chemistry at the University of North Carolina, said that the U.S. military is aggressively seeking to develop hCE1 as a battlefield reagent that could be used to detoxify sarin, soman, tabun, and VX gases. "Without the crystal structure, they have been making educated guesses as to where to make changes in the enzyme that would increase its efficiency in detoxifying these agents,” explained Dr. Redinbo. "Now, knowledge of the crystal structure takes much of the guesswork out of identifying the most effective modifications.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.